Completed PHASE2 INTERVENTIONAL 3-arm NCT01104467

Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke (DIAS-J)

Randomised, Double-blind, Placebo-controlled, Dose-escalation Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke

Sponsor: Lundbeck Japan K. K.

Conditions Acute Ischemic Stroke

Interventions Desmoteplase Placebo

Updated 6 times since 2017 Last updated: Aug 30, 2021 Started: Aug 31, 2010 Primary completion: Aug 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01104467, this PHASE2 trial focuses on Acute Ischemic Stroke and remains completed. Sponsored by Lundbeck Japan K. K., it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Sep 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lundbeck Japan K. K.

Data source: Lundbeck Japan K. K.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akita, Japan , Fukuoka, Japan , Hiroshima, Japan , Isesaki, Japan , Kagoshima, Japan , Kawasaki, Japan , Kobe, Japan , Kumamoto, Japan , Nagoya, Japan , Nishinomiya, Japan and 9 more locations